Huntington National Bank Makes New $42,000 Investment in agilon health, inc. (NYSE:AGL)

Huntington National Bank bought a new stake in agilon health, inc. (NYSE:AGL) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 21,900 shares of the company’s stock, valued at approximately $42,000.

Several other large investors also recently bought and sold shares of AGL. Symphony Financial Services Inc. grew its stake in shares of agilon health by 44.3% in the 4th quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock worth $44,000 after buying an additional 7,058 shares in the last quarter. Signaturefd LLC grew its position in agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after acquiring an additional 8,467 shares in the last quarter. Oak Thistle LLC purchased a new stake in agilon health during the fourth quarter valued at approximately $25,000. Ieq Capital LLC bought a new stake in shares of agilon health in the 4th quarter valued at approximately $26,000. Finally, Blair William & Co. IL boosted its holdings in shares of agilon health by 6.4% in the 4th quarter. Blair William & Co. IL now owns 254,759 shares of the company’s stock worth $484,000 after purchasing an additional 15,409 shares during the period.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and raised their price target for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Royal Bank of Canada lifted their price target on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Sanford C. Bernstein raised their price objective on shares of agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Finally, Stifel Nicolaus raised their price target on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $3.95.

agilon health Price Performance

Shares of AGL opened at $4.25 on Tuesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The company has a 50 day moving average price of $3.76 and a 200-day moving average price of $2.99. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The stock has a market capitalization of $1.75 billion, a PE ratio of -4.52 and a beta of 0.38.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.